Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $10.4 Million - $11.8 Million
-172,921 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $179,410 - $204,429
-3,167 Reduced 1.8%
172,921 $10.1 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $182,449 - $229,399
-2,938 Reduced 1.64%
176,088 $11.1 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $107,135 - $124,404
-1,481 Reduced 0.82%
179,026 $13.8 Million
Q4 2019

Feb 19, 2020

BUY
$61.62 - $67.78 $4,806 - $5,286
78 Added 0.04%
180,507 $11.7 Million
Q3 2019

Nov 05, 2019

SELL
$62.51 - $69.0 $57,321 - $63,273
-917 Reduced 0.51%
180,429 $11.4 Million
Q2 2019

Aug 12, 2019

SELL
$61.87 - $69.38 $38,483 - $43,154
-622 Reduced 0.34%
181,346 $12.3 Million
Q1 2019

May 07, 2019

SELL
$62.53 - $70.05 $25,824 - $28,930
-413 Reduced 0.23%
181,968 $11.8 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $8,657 - $11,297
143 Added 0.08%
182,381 $11.4 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $13,685 - $15,152
-192 Reduced 0.11%
182,238 $14.1 Million
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $2,919 - $3,405
-45 Reduced 0.02%
182,430 $12.9 Million
Q1 2018

May 14, 2018

BUY
$72.84 - $88.8 $38,095 - $46,442
523 Added 0.29%
182,475 $13.8 Million
Q4 2017

Feb 14, 2018

BUY
$71.15 - $83.52 $47,314 - $55,540
665 Added 0.37%
181,952 $13 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $13.1 Million - $15.5 Million
181,287
181,287 $14.7 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.